3649 results for «394»

Filter By

3649 results

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.

Mastering techniques from basic to complex - Imaging for aortic stenosis

16 Feb 2024 – From PCR Tokyo Valves 2024

Learn to master different imaging techniques for aortic stenosis through these slides. Gain insight into the concomitance of aortic stenosis and coronary artery disease, and learn about the pitfalls of aortic stenosis diagnosis in this session.

Rapid-fire - TAVI concomitant with CAD

17 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!

Which AF patients may benefit from LAA closure?

02 Jul 2026

Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.

Martin W. Bergmann

Author

Martin W. Bergmann
Which AF patients may benefit from LAA Closure?

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

20 May 2026

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis

24 Jun 2024

Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.

Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

From PROTECT-AF to CHAMPION-AF: Where do we stand today?

01 Jul 2026

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Jens-Erik-Nielsen-Kudsk

Author

Jens Erik Nielsen-Kudsk
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
Didn’t find what you were looking for?